correct. What’s the profit on $100mil supply of Keytruda?
Essentially Merck is paying peanuts. This is a zero risk equation for them and all the risk is on shareholders.
There’s no risk reduction for shareholders in this deal.running the trial. But $100 mil won’t cover it and all the other things they are doing. They will have to come back to the market again in 12 months.
running the trial. But $100 mil won’t cover it and all the other...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.045(13.2%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.0¢ | 29.5¢ | $1.468M | 4.740M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 37350 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 79295 | 3 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |